Impact of blood involvement on efficacy and time to response with mogamulizumab in mycosis fungoides and Sézary syndrome

BACKGROUND: Cutaneous T‐cell lymphomas (CTCL) are rare types of non‐Hodgkin lymphoma, which present in skin. Mycosis fungoides (MF) and Sézary syndrome (SS) are subtypes which make up two‐thirds of all CTCL cases. The phase 3 MAVORIC study (NCT01728805) compared mogamulizumab to vorinostat in MF and...

Descripción completa

Detalles Bibliográficos
Autores principales: Beylot‐Barry, Marie, Booken, Nina, Weishaupt, Carsten, Scarisbrick, Julia, Wu, Wende, Rosen, Jan‐Paul, Medley, Michael C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles and Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087984/
https://www.ncbi.nlm.nih.gov/pubmed/35993803
http://dx.doi.org/10.1111/jdv.18549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087984/
https://www.ncbi.nlm.nih.gov/pubmed/35993803
http://dx.doi.org/10.1111/jdv.18549

Ejemplares similares